Herbst, R. S., Garon, E. B., Kim, D., Chul Cho, B., Pérez Gracia, J. L., Han, J., Dubos Arvis, C., Majem, M., Forster, M., Monnet, I., Novello, S., Szalai, Z., Gubens, M. A., Su, W., Ceresoli, G. L., Samkari, A., Jensen, E., Lubiniecki, G. M., & Baas, P. (n.d.). lBA63Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095497668.0x00003c